OmniBRx Biotechnologies Pvt Ltd

We are in a strong position to offer upto 90% cost reduction in upstream bioprocessing for vaccine production, biologics manufacturing and cell therapies.

  • Stage Full Product Ready
  • Industry Biotechnology
  • Location Ahmedabad, Gujarat, India
  • Currency INR
  • Founded June 2016
  • Employees 8
  • Incorporation Type C-corp
  • Website omnibrx.com

Company Summary

Bioprocessing with adherent cell lines and stem cells have limitations of scalability, efficiency and affordability. With our proprietary DYNAMIC-BED REACTOR (DBR) technology, the CellBRx single-use bioreactors are in position to offer 60 to 90% cost reduction in upstream bioprocessing when compared with conventional technologies. Global SUB Market to reach USD 1.2 billion in 2021 (USD 0.45 billion in 2016). OmniBRx aimed to grasp at least 0.2%.

Team

  • Ravindra Patel
    CEO & Founder

    Having worked on almost every technology in the field of bioprocessing for more than 8 years, he has invented Dynamic Bed Reactor technology, with an aim to achieve greater heights in the field of bioprocessing.
    Mr. Ravindra Patel has enriched experience in cell culture techniques and bioprocess development: adherent & suspension cultures in disposable devices & stirred bioreactors.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free